IRVINE, Calif., April 28, 2026 /PRNewswire/ -- Laguna Diagnostics, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company's mRNA Gene Biomarker Test, a novel blood-based test designed to aid in the differentiation of...
Hence then, the article about u s fda grants breakthrough device designation to laguna diagnostics mrna gene biomarker test to aid in differentiation of schizophrenia and bipolar i disorder was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics' mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder )
Also on site :
- 1999 Box Office Flop Ranked Among ‘Best Movies of All Time’
- Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets
- Carrie Underwood Fans Do a Double Take at Her New Look Ahead of Taylor Swift Night on 'American Idol'